img

Global Siponimod Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 96 | Industry : Pharma & Healthcare

Publisher : Q | Format : PDF

Global Siponimod Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
0.25mg
0.2mg


Segment by Application


Retail Pharmacy
Hospital Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


Novartis

Table of Content

1 Siponimod Market Overview
1.1 Product Overview and Scope of Siponimod
1.2 Siponimod Segment by Type
1.2.1 Global Siponimod Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 0.25mg
1.2.3 0.2mg
1.3 Siponimod Segment by Application
1.3.1 Siponimod Sales Comparison by Application: (2021-2027)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Siponimod Market Size Estimates and Forecasts
1.4.1 Global Siponimod Revenue 2016-2027
1.4.2 Global Siponimod Sales 2016-2027
1.4.3 Siponimod Market Size by Region: 2016 Versus 2021 Versus 2027

2 Siponimod Market Competition by Manufacturers
2.1 Global Siponimod Sales Market Share by Manufacturers (2016-2021)
2.2 Global Siponimod Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Siponimod Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Siponimod Manufacturing Sites, Area Served, Product Type
2.5 Siponimod Market Competitive Situation and Trends
2.5.1 Siponimod Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Siponimod Players Market Share by Revenue
2.5.3 Global Siponimod Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Siponimod Retrospective Market Scenario by Region
3.1 Global Siponimod Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Siponimod Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Siponimod Market Facts & Figures by Country
3.3.1 North America Siponimod Sales by Country
3.3.2 North America Siponimod Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Siponimod Market Facts & Figures by Country
3.4.1 Europe Siponimod Sales by Country
3.4.2 Europe Siponimod Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Siponimod Market Facts & Figures by Region
3.5.1 Asia Pacific Siponimod Sales by Region
3.5.2 Asia Pacific Siponimod Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Siponimod Market Facts & Figures by Country
3.6.1 Latin America Siponimod Sales by Country
3.6.2 Latin America Siponimod Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Siponimod Market Facts & Figures by Country
3.7.1 Middle East and Africa Siponimod Sales by Country
3.7.2 Middle East and Africa Siponimod Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Siponimod Historic Market Analysis by Type
4.1 Global Siponimod Sales Market Share by Type (2016-2021)
4.2 Global Siponimod Revenue Market Share by Type (2016-2021)
4.3 Global Siponimod Price by Type (2016-2021)

5 Global Siponimod Historic Market Analysis by Application
5.1 Global Siponimod Sales Market Share by Application (2016-2021)
5.2 Global Siponimod Revenue Market Share by Application (2016-2021)
5.3 Global Siponimod Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Siponimod Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates

7 Siponimod Manufacturing Cost Analysis
7.1 Siponimod Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Siponimod
7.4 Siponimod Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Siponimod Distributors List
8.3 Siponimod Customers

9 Siponimod Market Dynamics
9.1 Siponimod Industry Trends
9.2 Siponimod Growth Drivers
9.3 Siponimod Market Challenges
9.4 Siponimod Market Restraints

10 Global Market Forecast
10.1 Siponimod Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Siponimod by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Siponimod by Type (2022-2027)
10.2 Siponimod Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Siponimod by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Siponimod by Application (2022-2027)
10.3 Siponimod Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Siponimod by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Siponimod by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Siponimod Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Siponimod Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Siponimod Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Siponimod Covered in This Study
Table 5. Global Siponimod Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Siponimod Sales Share by Manufacturers (2016-2021)
Table 7. Global Siponimod Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Siponimod Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Siponimod Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Siponimod Manufacturing Sites and Area Served
Table 11. Manufacturers Siponimod Product Type
Table 12. Global Siponimod Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Siponimod by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Siponimod as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Siponimod Sales by Region (2016-2021) & (K Units)
Table 16. Global Siponimod Sales Market Share by Region (2016-2021)
Table 17. Global Siponimod Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Siponimod Sales by Country (2016-2021) & (K Units)
Table 19. North America Siponimod Sales Market Share by Country (2016-2021)
Table 20. North America Siponimod Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Siponimod Revenue Market Share by Country (2016-2021)
Table 22. Europe Siponimod Sales by Country (2016-2021) & (K Units)
Table 23. Europe Siponimod Sales Market Share by Country (2016-2021)
Table 24. Europe Siponimod Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Siponimod Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Siponimod Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Siponimod Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Siponimod Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Siponimod Revenue Market Share by Region (2016-2021)
Table 30. Latin America Siponimod Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Siponimod Sales Market Share by Country (2016-2021)
Table 32. Latin America Siponimod Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Siponimod Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Siponimod Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Siponimod Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Siponimod Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Siponimod Revenue Market Share by Country (2016-2021)
Table 38. Global Siponimod Sales (K Units) by Type (2016-2021)
Table 39. Global Siponimod Sales Market Share by Type (2016-2021)
Table 40. Global Siponimod Revenue (Million US$) by Type (2016-2021)
Table 41. Global Siponimod Revenue Share by Type (2016-2021)
Table 42. Global Siponimod Price (US$/Unit) by Type (2016-2021)
Table 43. Global Siponimod Sales (K Units) by Application (2016-2021)
Table 44. Global Siponimod Sales Market Share by Application (2016-2021)
Table 45. Global Siponimod Revenue (Million US$) by Application (2016-2021)
Table 46. Global Siponimod Revenue Share by Application (2016-2021)
Table 47. Global Siponimod Price (US$/Unit) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Siponimod Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Novartis Siponimod Product
Table 52. Novartis Recent Developments/Updates
Table 53. Production Base and Market Concentration Rate of Raw Material
Table 54. Key Suppliers of Raw Materials
Table 55. Siponimod Distributors List
Table 56. Siponimod Customers List
Table 57. Siponimod Market Trends
Table 58. Siponimod Growth Drivers
Table 59. Siponimod Market Restraints
Table 60. Global Siponimod Sales Forecast by Type (2022-2027) & (K Units)
Table 61. Global Siponimod Sales Market Share Forecast by Type (2022-2027)
Table 62. Global Siponimod Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 63. Global Siponimod Revenue Market Share Forecast by Type (2022-2027)
Table 64. Global Siponimod Sales Forecast by Application (2022-2027) & (K Units)
Table 65. Global Siponimod Sales Market Share Forecast by Application (2022-2027)
Table 66. Global Siponimod Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 67. Global Siponimod Revenue Market Share Forecast by Application (2022-2027)
Table 68. Global Siponimod Sales Forecast by Region (2022-2027) & (K Units)
Table 69. Global Siponimod Sales Market Share Forecast by Region (2022-2027)
Table 70. Global Siponimod Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 71. Global Siponimod Revenue Market Share Forecast by Region (2022-2027)
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Siponimod
Figure 2. Global Siponimod Market Share by Type in 2020 & 2027
Figure 3. 0.25mg Product Picture
Figure 4. 0.2mg Product Picture
Figure 5. Global Siponimod Market Share by Application in 2020 & 2027
Figure 6. Retail Pharmacy
Figure 7. Hospital Pharmacy
Figure 8. Other
Figure 9. Global Siponimod Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Siponimod Market Size 2016-2027 (US$ Million)
Figure 11. Global Siponimod Sales 2016-2027 (K Units)
Figure 12. Global Siponimod Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Siponimod Sales Share by Manufacturers in 2020
Figure 14. Global Siponimod Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Siponimod Players: Market Share by Revenue in 2020
Figure 16. Siponimod Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Siponimod Sales Market Share by Region (2016-2021)
Figure 18. Global Siponimod Sales Market Share by Region in 2020
Figure 19. Global Siponimod Revenue Market Share by Region (2016-2021)
Figure 20. Global Siponimod Revenue Market Share by Region in 2020
Figure 21. U.S. Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Siponimod Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Siponimod by Type (2016-2021)
Figure 46. Sales Market Share of Siponimod by Application (2016-2021)
Figure 47. Sales Market Share of Siponimod by Application in 2020
Figure 48. Revenue Share of Siponimod by Application (2016-2021)
Figure 49. Revenue Share of Siponimod by Application in 2020
Figure 50. Manufacturing Cost Structure of Siponimod
Figure 51. Manufacturing Process Analysis of Siponimod
Figure 52. Siponimod Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed